MDC

M.D.C. HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of M.D.C. Holdings, Inc. - MDC

Retrieved on: 
Wednesday, February 7, 2024

and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of M.D.C. Holdings, Inc. (NYSE: MDC) to Sekisui House, Ltd.

Key Points: 
  • and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of M.D.C. Holdings, Inc. (NYSE: MDC) to Sekisui House, Ltd.
  • Under the terms of the proposed transaction, shareholders of M.D.C. will receive $63.00 in cash for each share of M.D.C. that they own.
  • KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
  • To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .

CWCI Analyzes California Workers’ Comp Inpatient Care

Retrieved on: 
Wednesday, January 31, 2024

A new analysis by the California Workers’ Compensation Institute (CWCI) uses data on 28.7 million inpatient hospital stays with 2012 through 2022 discharge dates compiled by the California Department of Health Care Access and Information (HCAI) to measure and compare the use of inpatient services and procedures covered by workers’ compensation, Medicare, Medi-Cal and private coverage.

Key Points: 
  • A new analysis by the California Workers’ Compensation Institute (CWCI) uses data on 28.7 million inpatient hospital stays with 2012 through 2022 discharge dates compiled by the California Department of Health Care Access and Information (HCAI) to measure and compare the use of inpatient services and procedures covered by workers’ compensation, Medicare, Medi-Cal and private coverage.
  • The most recent data suggest that many of those factors continue to help contain the volume of workers’ comp inpatient stays, as unlike the other systems where inpatient hospitalizations have rebounded after falling sharply in 2020 (the first year of the pandemic), workers’ comp inpatient stays have continued to drop.
  • With the recent decline in COVID-related hospitalizations, the distribution of workers’ comp inpatient stays by diagnosis shifted back toward pre-pandemic levels.
  • CWCI has issued a Research Update Report on its study, “Utilization of Inpatient Care in California Workers’ Compensation, 2012-2022.” CWCI members and subscribers can access the report and a summary Bulletin at www.cwci.org .

Richmond American Announces its Debut Middleton Community

Retrieved on: 
Wednesday, January 31, 2024

MIDDLETON, Idaho, Jan. 31, 2024 /PRNewswire/ -- Richmond American Homes of Idaho, Inc., a subsidiary of M.D.C. Holdings, Inc. (NYSE: MDC), is excited to announce that Seasons at Stonehaven (RichmondAmerican.com/ SeasonsAtStonehaven) is now open for sales in Middleton. Boasting a prime location just 30 minutes from Boise, this exceptional new neighborhood offers single and two-story floor plans from the builder's sought-after Seasons™ Collection, designed to make homeownership more attainable for a variety of buyers.

Key Points: 
  • Seasons at Stonehaven is now selling!
  • MIDDLETON, Idaho, Jan. 31, 2024 /PRNewswire/ -- Richmond American Homes of Idaho, Inc., a subsidiary of M.D.C. Holdings, Inc. (NYSE: MDC), is excited to announce that Seasons at Stonehaven ( RichmondAmerican.com/ SeasonsAtStonehaven ) is now open for sales in Middleton.
  • Boasting a prime location just 30 minutes from Boise, this exceptional new neighborhood offers single and two-story floor plans from the builder's sought-after Seasons™ Collection, designed to make homeownership more attainable for a variety of buyers.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Rover Group, Inc. (Nasdaq - ROVR), M.D.C. Holdings, Inc. (NYSE - MDC), Taro Pharmaceutical Industries Ltd. (NYSE - TARO), PGT Innovations Inc. (NYSE - PGTI)

Retrieved on: 
Friday, January 26, 2024

If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.

Key Points: 
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the agreement, Rover will be acquired by private equity funds managed by Blackstone in an all-cash transaction valued at approximately $2.3 billion.
  • Under the terms of the agreement, Rover stockholders will receive $11.00 per share in cash for each share of Rover they own.
  • Under the terms of the agreement, Taro will be acquired by Sun Pharmaceutical Industries Limited (“Sun Pharma”), Taro’s controlling shareholder.

SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – MDC, HARP, CVLY, AXNX

Retrieved on: 
Wednesday, January 24, 2024

Under the terms of the agreement, MDC shareholders are expected to receive $63.00 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, MDC shareholders are expected to receive $63.00 in cash per share they own.
  • It is free and there is no cost or obligation to you.
  • Under the terms of the agreement, HARP shareholders will receive $23.00 in cash per share they own.
  • Under the terms of the agreement, AXNX shareholders will receive $71.00 in cash per share they own.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Rover Group, Inc. (Nasdaq - ROVR), M.D.C. Holdings, Inc. (NYSE - MDC), Taro Pharmaceutical Industries Ltd. (NYSE - TARO), PGT Innovations Inc. (NYSE - PGTI)

Retrieved on: 
Monday, January 22, 2024

If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.

Key Points: 
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the agreement, Rover will be acquired by private equity funds managed by Blackstone in an all-cash transaction valued at approximately $2.3 billion.
  • Under the terms of the agreement, Rover stockholders will receive $11.00 per share in cash for each share of Rover they own.
  • Under the terms of the agreement, Taro will be acquired by Sun Pharmaceutical Industries Limited (“Sun Pharma”), Taro’s controlling shareholder.

STOCKHOLDER ALERT: Juan Monteverde Encourages the Shareholders of TCN, KAMN, MDC, TARO to Take Action

Retrieved on: 
Saturday, January 20, 2024

Under the terms of the agreement, TCN shareholders are expected to receive $11.25 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, TCN shareholders are expected to receive $11.25 in cash per share they own.
  • Under the terms of the agreement, KAMN shareholders are expected to receive $46.00 in cash per share they own.
  • Taro Pharmaceutical Industries Ltd. (NYSE: TARO ), relating to its proposed sale to Sun Pharmaceutical Industries Ltd.
  • Under the terms of the agreement, TARO shareholders are expected to receive $43.00 in cash per share they own.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: M.D.C. Holdings, Inc. (NYSE - MDC), Cornerstone Financial Corporation (OTC - CFIC), Taro Pharmaceutical Industries Ltd. (NYSE - TARO), PGT Innovations Inc. (NYSE - PG

Retrieved on: 
Thursday, January 18, 2024

If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.

Key Points: 
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the agreement, MDC will be acquired by Sekisui House, Ltd. (“Sekisui House”).
  • MDC shareholders will receive $63.00 per share in cash in a deal with an equity value of $4.9 billion.
  • Under the terms of the agreement, Taro will be acquired by Sun Pharmaceutical Industries Limited (“Sun Pharma”), Taro’s controlling shareholder.

SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Sale of M.D.C. Holdings; Are MDC Shareholders Getting a Fair Deal?

Retrieved on: 
Thursday, January 18, 2024

SAN DIEGO, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of M.D.C. Holdings, Inc. (NYSE: MDC) (“M.D.C.” or “the Company”) breached their fiduciary duties in connection with the proposed sale of the Company to Sekisuio House.

Key Points: 
  • SAN DIEGO, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of M.D.C. Holdings, Inc. (NYSE: MDC) (“M.D.C.” or “the Company”) breached their fiduciary duties in connection with the proposed sale of the Company to Sekisuio House.
  • You can click on the following link to join this investigation:
    On January 18, 2024, M.D.C. announced that it had entered a deal to merge with Sekisuio.
  • Under the terms of the deal, M.D.C. shareholders will receive $63.00 per share in an all-cash offer.
  • Nationally recognized, Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given analysts' projections for future earnings and revenue growth.

Midland Development Corporation and MITRE Sign Agreement to Advance Spaceports

Retrieved on: 
Thursday, January 25, 2024

MITRE and the Midland Development Corporation (MDC), the economic development organization for Midland, Texas, signed an agreement to work together to accelerate their common vision for commercial space and high-speed flight operations in the United States.

Key Points: 
  • MITRE and the Midland Development Corporation (MDC), the economic development organization for Midland, Texas, signed an agreement to work together to accelerate their common vision for commercial space and high-speed flight operations in the United States.
  • MDC and MITRE will cooperate on research and development projects and operational demonstrations that are of critical importance to enabling commercial space and high-speed flight operations at Midland International Air and Space Port.
  • Working together, MITRE and MDC will focus on enabling early advancements to accelerate operational learning and coordinate essential information for decision makers.
  • MITRE is working across government and industry to help create an integrated transportation experience from surface to space.